Design Therapeutics Statistics

Total Valuation

DSGN has a market cap or net worth of $205.81 million. The enterprise value is -$67.22 million.

Market Cap	205.81M
Enterprise Value	-67.22M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

DSGN has 56.00 million shares outstanding. The number of shares has increased by 0.50% in one year.

Shares Outstanding	56.00M
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	36.67%
Owned by Institutions (%)	56.79%
Float	24.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.76
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 29.58, with a Debt / Equity ratio of 0.01.

Current Ratio	29.58
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.80% and return on invested capital (ROIC) is -27.92%.

Return on Equity (ROE)	-22.80%
Return on Assets (ROA)	-21.80%
Return on Capital (ROIC)	-27.92%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	58
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.98% in the last 52 weeks. The beta is 1.83, so DSGN's price volatility has been higher than the market average.

Beta (1Y)	1.83
52-Week Price Change	-26.98%
50-Day Moving Average	3.01
200-Day Moving Average	3.27
Relative Strength Index (RSI)	61.35
Average Volume (30 Days)	260,761

Short Selling Information

The latest short interest is 2.23 million, so 3.98% of the outstanding shares have been sold short.

Short Interest	2.23M
Short Previous Month	2.14M
Short % of Shares Out	3.98%
Short % of Float	9.24%
Short Ratio (days to cover)	7.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-78.19M
Pretax Income	-66.86M
Net Income	-66.86M
EBITDA	-66.29M
EBIT	-66.86M
Earnings Per Share (EPS)	-$1.19

Full Income Statement

Balance Sheet

The company has $281.80 million in cash and $2.33 million in debt, giving a net cash position of $279.46 million or $4.99 per share.

Cash & Cash Equivalents	281.80M
Total Debt	2.33M
Net Cash	279.46M
Net Cash Per Share	$4.99
Equity / Book Value	277.69M
Book Value Per Share	4.96
Working Capital	274.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.56 million and capital expenditures -$256,000, giving a free cash flow of -$58.82 million.

Operating Cash Flow	-58.56M
Capital Expenditures	-256,000
Free Cash Flow	-58.82M
FCF Per Share	-$1.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DSGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	-0.50%
Earnings Yield	-31.50%
FCF Yield	-27.71%

Analyst Forecast

The average price target for DSGN is $5.00, which is 35.14% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	35.14%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.30%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2